Pharmaceutical reimbursement

Pink Sheet

UK Gov't Disowns ‘Secret’ Meetings With US On Post-Brexit Drug Pricing

Brexit and the NHS are likely to be key issues as political parties in the UK prepare to campaign ahead of the general election in December. 

Topic Pharma-Brexit Reimbursement

Scrip

Novartis Sees Reimbursement Advantage For PCSK9 Launch

Administration under the medical benefit/Medicare Part B could mean easier reimbursement. The company outlined early plans for the launch of inclisiran after announcing it will buy The Medicines Company for $9.7bn.

Topic Business Strategies Deal trends Reimbursement

Datamonitor Healthcare

Multiple Myeloma Pricing, Reimbursement, and Access

Disease management and treatment programmes change, as research evolves and new discoveries are made. Your market access strategies must evolve too.

Topic Cancer Drug development landscape Reimbursement

Topic Reimbursement

Datamonitor Healthcare

Market Access Data that makes sense

How can you find current quantitative and qualitative evidence that informs your market access strategy?

Topic Reimbursement

Pink Sheet

Goodbye CFDA, Hello MRA: China Overhauls Regulatory Bodies

China proposes to merge its top drug regulator into new combined body, and creates a medical reimbursement agency in move viewed as sign of strengthening regulatory oversight.

Topic Reimbursement Drug review

Medtech Insight

NEST Coordinating Center At Year One: Device Data-Sharing Network In Its Sights

A year after the NEST Coordinating Center was launched, the group has expanded its staff.

Topic Reimbursement

Medtech Insight

Lingering Debt And New E-Procurement System Await Turkish Medtech

2017 saw developments that were beneficial to the Turkish medtech industry, like the continued progress of the billion-dollar City Hospitals project.

Topic Reimbursement